Back to Mackenzie Financial Corp. Mackenzie Financial Corp.

MRNAMRNA

Showing 9 of 26 quarters

Position history for Mackenzie Financial Corp.Mackenzie Financial Corp.'s holdings in Moderna, Inc.

Yes. Mackenzie Financial holds 225,823 shares of MRNA (Moderna), worth $43.5M, as of its Q3 2026 13F filing. It increased the position by 109,578 shares (+94.3%) from Q2 2026. Mackenzie Financial has held MRNA since Q2 2020, across 26 quarterly 13F filings.

Current Value

$43.5M

Current Shares

225,823

Total Value Change

+$41.5M

Total Shares Change

+195,617

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
225,823
+94.3%
$43.5M0.0%$192.57
46
2026-Q2
Increased
116,245
+211.1%
$8.1M0.0%$70.03
44
2026-Q1
Increased
37,365
+217.5%
$1.9M0.0%$50.80
42
2025-Q4
Increased
11,767
+5.0%
$357,1300.0%$29.49
25
2025-Q3
Decreased
11,201
-0.7%
$289,3220.0%$25.83
0
2025-Q2
Decreased
11,283
-64.1%
$311,2980.0%$27.59
0
2025-Q1
Increased
31,441
+14.3%
$891,3520.0%$28.35
28
2024-Q4
Decreased
27,519
-8.9%
$1.1M0.0%$41.58
0
2024-Q3
Decreased
30,206
-36.6%
$2M0.0%$65.75
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used